Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Bi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Nature Immunology|October 23, 2019
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodelingFlavian D Brown, Debattama R Sen, Martin W LaFleur, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticityErica M Pimenta, Amanda E Garza, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell epigenetic profiling reveals an interferon response-high program associated with <i>BAP1</i> deficiency in kidney cancerSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancerFilipe Lf Carvalho, Jihyun Lee, Nikolaos Kalavros, et al.
Science Advances|February 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and <i>BAP1</i> lossSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Science Translational Medicine|January 21, 2026
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticityErica M Pimenta, Amanda E Garza, Sabrina Y Camp, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Nature Immunology|October 23, 2019
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodelingFlavian D Brown, Debattama R Sen, Martin W LaFleur, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticityErica M Pimenta, Amanda E Garza, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell epigenetic profiling reveals an interferon response-high program associated with <i>BAP1</i> deficiency in kidney cancerSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancerFilipe Lf Carvalho, Jihyun Lee, Nikolaos Kalavros, et al.
Science Advances|February 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and <i>BAP1</i> lossSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Science Translational Medicine|January 21, 2026
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticityErica M Pimenta, Amanda E Garza, Sabrina Y Camp, et al.
Pageof 4